As long as you're on the same track, there's no way to overtake on a curve; overtaking on a curve is just self-deception.
Yang Ping certainly understands this principle. If he continues to research adjuvants, even with the support of System Space, which provides ample trial and error experiences, he would still be a follower. Now he's pondering whether he can switch tracks to completely overturn the table.
The purpose of vaccine adjuvants is to enhance antigenicity. If it were possible to develop a new technology that could also enhance immune antigens, such as using the loading technology of K Therapy to load a functional protein onto the vaccine, then he would achieve better enhancement than adjuvants, rendering adjuvants meaningless.
